this is a 352 paitent study. although only P2 still expensive study. started last month. makes you wonder why MRK started this study now and not wait two months. or do you think they dont realy have to wait two months because they already know the results? or have commited to RIDA whatever the results? Plus why do they include a RIDA only arm if they dont think it will be a single agent drug?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.